作为动物及细胞实验最重要的载体之一，重组腺相关病毒（recombinant AAV, rAAV）可携带目的基因片段，其衣壳内的基因组中编码病毒蛋白的部分完全被删除，取而代之的是治疗性的转基因或基因编辑工具，加上不同血清型rAAV的组织嗜性与载体设计的灵活性及特异性 ...

At least 17 different companies are conducting clinical trials for rAAV-based gene therapies, with three programs now in phase-3 trials. This surge in interest has brought a boom in demand for ...

Quebec's four statutory museums and two major artists' associations are thrilled to announce the ratification of the first ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

Accordingly, the large majority of recombinant adeno-associated virus (rAAV)-based therapies—which account for most gene therapies—are still produced with a method developed more than two ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...